PD1

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer

Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients

A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients

Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy

Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma

Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma

Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma

Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer

Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma

Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ